Medicinos namai - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 84,947 | 92,688 | 91,806 | 606,049 | 689,429 | 792,602 | 8,135,034 |
| Profit before tax | - | - | - | - | -29,290 | -50,150 | 27,744 | 1,087,098 |
| Net profit | - | - | - | - | -29,290 | -50,150 | 27,744 | 1,087,098 |
| Equity | 37,840 | 62,127 | 128,288 | 149,730 | 120,409 | 70,259 | 98,003 | 3,740,674 |
| Liabilities | 24,429 | 40,148 | 43,491 | 56,836 | 56,701 | 53,096 | 59,284 | 7,419,833 |
| Non-current assets | 6,520 | 6,118 | 6,765 | 11,927 | 19,474 | 17,658 | 17,448 | 6,854,341 |
| Current assets | 55,749 | 96,157 | 165,014 | 194,639 | 157,636 | 105,697 | 139,839 | 3,212,259 |
| Total assets | 62,269 | 102,275 | 171,779 | 206,566 | 177,110 | 123,355 | 157,287 | 10,066,600 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 119,005 | 117,701 | 724,849 |
| Social insurance contributions | - | - | - | - | - | 126,972 | 137,991 | 990,934 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +9.1% | -1.0% | +560.1% | +13.8% | +15.0% | +926.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | -16.5% | -40.7% | 17.6% | 10.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | -24.3% | -71.4% | 28.3% | 29.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | -4.8% | -7.3% | 3.5% | 13.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | -4.8% | -7.3% | 3.5% | 13.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 0.6 | 0.3 | 0.4 | 0.5 | 0.8 | 0.6 | 2.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 3,951 | 4,311 | 4,080 | 25,429 | 26,517 | 31,810 | 40,948 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medicinos namai - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-12-16 | 2025-12-16 | 294074.34 |
| 2024-08-19 | 2024-08-21 | 1552.54 |
| 2024-06-18 | 2024-06-24 | 470.51 |
| 2024-05-16 | 2024-05-19 | 229.50 |
| 2024-04-16 | 2024-04-18 | 133.21 |
| 2023-09-18 | 2023-09-20 | 152.86 |
| 2023-07-18 | 2023-07-19 | 1362.31 |
| 2023-05-16 | 2023-06-08 | 0.07 |
| 2023-05-02 | 2023-05-10 | 0.07 |
| 2023-04-26 | 2023-04-28 | 0.07 |
| 2023-01-17 | 2023-01-18 | 145.51 |
| 2022-02-17 | 2022-03-13 | 0.03 |
| 2022-01-31 | 2022-02-13 | 0.03 |
| 2021-10-18 | 2021-10-25 | 7.90 |
Medicinos namai - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Medicinos namai is: 5 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 4.71 |
| 2026-08-06 | 2026-08-07 | 172.02 |
| 2026-05-17 | 2026-05-18 | 161.04 |
| 2026-05-13 | 2026-05-16 | 153.42 |
| 2026-03-13 | 2026-03-17 | 2.37 |
| 2026-02-18 | 2026-02-21 | 4.35 |
| 2026-01-29 | 2026-02-17 | 2.66 |
| 2026-01-16 | 2026-01-16 | 0.98 |
| 2025-12-17 | 2025-12-17 | 4.97 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medicinos namai, UAB (code 124363274) is a Private Limited Liability Company engaged in general medical practice activities. In 2025, the company generated revenue of €8.14M and net profit of €1.09M, corresponding to a profit margin of 13.4%. This marks a very strong improvement from 2024, when revenue was €792.6K and net profit €27.7K, and from 2023, when revenue was €689.4K and the company recorded a net loss of €50.1K. The three-year trend shows a shift from a small loss to moderate profitability and then to a large-scale expansion in 2025, with revenue growth of 926.4% year on year. At year-end 2025, total assets amounted to €10.07M, equity to €3.74M and liabilities to €7.42M. The equity ratio was 37.2% and debt-to-equity stood at 1.98. Return on equity was 29.1%, return on assets 10.8% and asset turnover 0.81x. Revenue per employee was €41.1K and profit per employee €5.5K.